AN2 Therapeutics, Inc. (ANTX)

NMS – Real Time Price. Currency in USD

6.32

+0.45 (7.67%)

Market open: Aug 12, 2026, 3:00 PM EDT

5.87

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:45 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-77K

Gross Profit

-77K

Operating expenses (excl. COGS)

-38M

-55M

-70M

-42M

Operating Income

-38M

-55M

-70M

-42M

Non-operating income, total

Pretax income

-35M

-51M

-65M

-41M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-35M

-51M

-65M

-41M

Discontinued operations

Net income

-35M

-51M

-65M

-41M

Dilution adjustment

Preferred dividends

AN2 Therapeutics, Inc. (ANTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AN2 Therapeutics, Inc. (ANTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

AN2 Therapeutics, Inc. (ANTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AN2 Therapeutics, Inc. (ANTX)

Income Statement (Annual)

Income Statement (Annual)